David Ripstein (CRNT) discloses Ceragon share and stock option holdings in Form 3
Rhea-AI Filing Summary
Ceragon Networks director David Ripstein filed an initial Form 3 showing his equity position in the company. He directly holds 32,010 Ordinary Shares, with some of these shares issued upon vesting of previously granted RSUs. In addition, he holds several fully vested and immediately exercisable stock options over Ordinary Shares at different exercise prices and expirations, including options over 7,397 shares at an exercise price of $3.7010 expiring in July 2027, and options over 16,666 shares at $2.0900 and 16,666 shares at $1.9900 expiring in July 2029 and September 2029. He also holds options over 26,790 shares at $3.0800 expiring in May 2030, and two grants of options over 14,850 shares and 33,700 shares at an exercise price of $2.4500 expiring in May 2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (2)
- F1. These shares were issued upon vesting of previously granted RSU's
- F2. The Stock Options are Fully vested and immediately exercisable
AI-generated analysis. How Rhea-AI works. Not financial advice.
